Overview

A Phase II Multi-centre, Extension Study to Investigate the Long Term Safety of ONO-2506PO in Patients Diagnosed With Amyotrophic Lateral Sclerosis (ALS)

Status:
Completed

Trial end date:
1969-12-31

Target enrollment:

Participant gender:

Summary

The objective of this study is to investigate the long term safety of ALS patients taking ONO-2506PO.

Phase:

Phase 2

Details

Lead Sponsor:

Ono Pharmaceutical Co. Ltd